291 related articles for article (PubMed ID: 24516016)
1. CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.
Bulian P; Shanafelt TD; Fegan C; Zucchetto A; Cro L; Nückel H; Baldini L; Kurtova AV; Ferrajoli A; Burger JA; Gaidano G; Del Poeta G; Pepper C; Rossi D; Gattei V
J Clin Oncol; 2014 Mar; 32(9):897-904. PubMed ID: 24516016
[TBL] [Abstract][Full Text] [Related]
2. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
[TBL] [Abstract][Full Text] [Related]
3. CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
Majid A; Lin TT; Best G; Fishlock K; Hewamana S; Pratt G; Yallop D; Buggins AG; Wagner S; Kennedy BJ; Miall F; Hills R; Devereux S; Oscier DG; Dyer MJ; Fegan C; Pepper C
Leuk Res; 2011 Jun; 35(6):750-6. PubMed ID: 21093051
[TBL] [Abstract][Full Text] [Related]
4. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
Gattei V; Bulian P; Del Principe MI; Zucchetto A; Maurillo L; Buccisano F; Bomben R; Dal-Bo M; Luciano F; Rossi FM; Degan M; Amadori S; Del Poeta G
Blood; 2008 Jan; 111(2):865-73. PubMed ID: 17959854
[TBL] [Abstract][Full Text] [Related]
5. CD49d and CD26 are independent prognostic markers for disease progression in patients with chronic lymphocytic leukemia.
Ibrahem L; Elderiny WE; Elhelw L; Ismail M
Blood Cells Mol Dis; 2015 Aug; 55(2):154-60. PubMed ID: 26142332
[TBL] [Abstract][Full Text] [Related]
6. High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.
Nückel H; Switala M; Collins CH; Sellmann L; Grosse-Wilde H; Dührsen U; Rebmann V
Clin Immunol; 2009 Jun; 131(3):472-80. PubMed ID: 19318232
[TBL] [Abstract][Full Text] [Related]
7. CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.
Shanafelt TD; Geyer SM; Bone ND; Tschumper RC; Witzig TE; Nowakowski GS; Zent CS; Call TG; Laplant B; Dewald GW; Jelinek DF; Kay NE
Br J Haematol; 2008 Mar; 140(5):537-46. PubMed ID: 18275431
[TBL] [Abstract][Full Text] [Related]
8. The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
Brachtl G; Piñón Hofbauer J; Greil R; Hartmann TN
Ann Hematol; 2014 Mar; 93(3):361-74. PubMed ID: 24288111
[TBL] [Abstract][Full Text] [Related]
9. THE PROGNOSTIC SIGNIFICANCE OF COMBAIND EXPRESSION OF ZAP-70 AND CD38 IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Kirtava T; Vatsadze T; Azrmaiparashili E; Ghirdaladze D
Georgian Med News; 2017 Jun; (267):12-16. PubMed ID: 28726646
[TBL] [Abstract][Full Text] [Related]
10. CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia.
Dal Bo M; Bulian P; Bomben R; Zucchetto A; Rossi FM; Pozzo F; Tissino E; Benedetti D; Bittolo T; Nanni P; Cattarossi I; Zaina E; Chivilò H; Degan M; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Del Principe MI; Del Poeta G; Rossi D; Gaidano G; Gattei V
Leukemia; 2016 Oct; 30(10):2011-2018. PubMed ID: 27109509
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia.
Shanafelt TD; Drake MT; Maurer MJ; Allmer C; Rabe KG; Slager SL; Weiner GJ; Call TG; Link BK; Zent CS; Kay NE; Hanson CA; Witzig TE; Cerhan JR
Blood; 2011 Feb; 117(5):1492-8. PubMed ID: 21048153
[TBL] [Abstract][Full Text] [Related]
12. ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive value.
Hus I; Bojarska-Junak A; Dmoszyńska A; Wasik-Szczepanek E; Sieklucka M; Trześniewska W; Glazer M; Roliński J
Folia Histochem Cytobiol; 2008; 46(2):147-52. PubMed ID: 18519230
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia.
Hus I; Podhorecka M; Bojarska-Junak A; Roliński J; Schmitt M; Sieklucka M; Wasik-Szczepanek E; Dmoszyńska A
Ann Oncol; 2006 Apr; 17(4):683-90. PubMed ID: 16524977
[TBL] [Abstract][Full Text] [Related]
14. Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.
Claus R; Lucas DM; Ruppert AS; Williams KE; Weng D; Patterson K; Zucknick M; Oakes CC; Rassenti LZ; Greaves AW; Geyer S; Wierda WG; Brown JR; Gribben JG; Barrientos JC; Rai KR; Kay NE; Kipps TJ; Shields P; Zhao W; Grever MR; Plass C; Byrd JC
Blood; 2014 Jul; 124(1):42-8. PubMed ID: 24868078
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
16. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
Rassenti LZ; Jain S; Keating MJ; Wierda WG; Grever MR; Byrd JC; Kay NE; Brown JR; Gribben JG; Neuberg DS; He F; Greaves AW; Rai KR; Kipps TJ
Blood; 2008 Sep; 112(5):1923-30. PubMed ID: 18577710
[TBL] [Abstract][Full Text] [Related]
17. The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.
Zucchetto A; Vaisitti T; Benedetti D; Tissino E; Bertagnolo V; Rossi D; Bomben R; Dal Bo M; Del Principe MI; Gorgone A; Pozzato G; Gaidano G; Del Poeta G; Malavasi F; Deaglio S; Gattei V
Leukemia; 2012 Jun; 26(6):1301-12. PubMed ID: 22289918
[TBL] [Abstract][Full Text] [Related]
18. CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia.
Xu W; Li JY; Wu YJ; Yu H; Shen QD; Tian T; Li L; Qiu HX
Leuk Res; 2009 Feb; 33(2):237-43. PubMed ID: 18674817
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia.
Del Principe MI; Del Poeta G; Buccisano F; Maurillo L; Venditti A; Zucchetto A; Marini R; Niscola P; Consalvo MA; Mazzone C; Ottaviani L; Panetta P; Bruno A; Bomben R; Suppo G; Degan M; Gattei V; de Fabritiis P; Cantonetti M; Lo Coco F; Del Principe D; Amadori S
Blood; 2006 Aug; 108(3):853-61. PubMed ID: 16601244
[TBL] [Abstract][Full Text] [Related]
20. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
Deaglio S; Vaisitti T; Aydin S; Ferrero E; Malavasi F
Blood; 2006 Aug; 108(4):1135-44. PubMed ID: 16621959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
